Posts Tagged Voice disorders

This clinical report presents real-world clinical data on the use of LSVT LOUD to improve the communication of one preschooler and one young adult with cerebral palsy (CP). Treatment resulted in significant improvements in vocal loudness, communicative effectiveness, participation, and speech (for both clients) and velopharyngeal function (for the young adult) / Notre article clinique rapporte des données cliniques « réelles » relatives à l’utilisation du protocole LSVT LOUD pour améliorer la communication d’une enfant d’âge préscolaire et d’un jeune adulte ayant une paralysie cérébrale. L’intervention offerte a permis d’améliorer de façon significative l’intensité vocale, l’efficacité de la communication, la participation communicative et la parole (chez les deux patient(e)s), ainsi que la fonction vélopharyngée (chez le jeune adulte).

Continue Reading →

This study investigated whether untrained listeners who are recruited through online crowdsourcing platforms can assess voice treatment for people with Parkinson’s Disease (PD) in a way that agrees with reliable measurement tools. In crowdsourcing, researchers use digital platforms to connect with a large number of individuals who perform tasks online for monetary compensation.

Continue Reading →

This study presents the first randomized controlled trial (RCT) examining the effects of two speech treatment approaches, LSVT LOUD and LSVT ARTIC, on voice quality in individuals with Parkinson’s disease (PD). Both treatments were identical in how intensive they were, but LSVT LOUD targeted healthy loudness, whereas LSVT ARTIC focused on articulation. Additionally, an untreated group of individuals with PD also participated in the study, and a group of 20 individuals without PD were included to examine differences in voice quality at pre-treatment.

Continue Reading →

This study looked at speech and brain changes in individuals with Parkinson’s disease following two speech treatment approaches, matched for intensity of dosage (16, 1-hour individual sessions in one month) but differing on treatment target, loudness (LSVT LOUD) or articulation (LSVT ARTIC). A group of untreated individuals with Parkinson’s disease were also studied as a comparison group. All participants were evaluated at baseline, post-treatment (one month after baseline), and seven months after baseline to help identify both short-term and long-term changes.  

Continue Reading →